🔎 Trials Near Me

Início › Linfoma de Burkitt › Virgínia

Ensaios clínicos de Linfoma de Burkitt em Virgínia

7 estudos para Linfoma de Burkitt estão buscando participantes em locais em Virgínia.

Cidades em Virgínia

Texto oficial do estudo (Inglês)

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

  • University of Virginia Cancer Center, Charlottesville
  • Inova Fairfax Hospital, Falls Church
  • Children's Hospital of The King's Daughters, Norfolk
  • e mais 2
RecrutandoFase 2
366 Days – 46 Years · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT06124157

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

  • VCU Massey Comprehensive Cancer Center, Richmond
RecrutandoFase 3
Idades de 18 a 39 · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT03150693

Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia

  • VCU Massey Comprehensive Cancer Center, Richmond
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT03739814

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

  • University of Virginia Cancer Center, Charlottesville
  • Children's Hospital of The King's Daughters, Norfolk
  • VCU Massey Comprehensive Cancer Center, Richmond
  • e mais 1
RecrutandoFase 2
365 Days · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06317662

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

  • Inova Fairfax Hospital, Falls Church
  • Children's Hospital of The King's Daughters, Norfolk
  • VCU Massey Comprehensive Cancer Center, Richmond
RecrutandoFase 2
Idades de 1 a 30 · Todos os sexos · Atualizado em 1 de set. de 2026 · NCT04546399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

  • University of Virginia Cancer Center, Charlottesville
  • Inova Fairfax Hospital, Falls Church
  • Children's Hospital of The King's Daughters, Norfolk
  • e mais 3
RecrutandoFase 3
365 Days – 25 Years · Todos os sexos · Atualizado em 25 de ago. de 2026 · NCT03959085

AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia

  • Research Site, Richmond
RecrutandoFase 1/2
Idades 12 e acima · Todos os sexos · Atualizado em 19 de ago. de 2026 · NCT06137118

Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.